Full Text (PDF)
Original Article

Pentoxifylline in combination with ACEI & ARB resulting in significant decline of proteinuria

Swapnil Singh Kushwaha , Swapnil Singh Kushwaha , Prateek Shrama , Utkarash Mishra

Author Information

Licence:




New Indian Journal of Surgery 2(4):p 383-383, October-December 2011. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 In India, Proteinuria is quite common, occurring in upto 50% of patients, resulting in decreased patient survival and increased prevalence of cardiovascular disease. ACE inhibitors (ACEI) & Angiotensin receptor blockers (ARB) have been the mainstay of therapy in native kidney proteinuria, though may not succeed in all patients because of side effects. Pentoxyfylline has been advocated as an anti-inflammatory measure, probably contributing to amelioration of proteinuria. Decreasing proteinuria is the mainstay of therapy in order to delay the progression of CKD. Burden of disease Diabetic nephropathy (DN) is the main cause of endstage renal disease (ESRD). Diabetic Nephropathy is the leading cause of DM-related morbidity and mortality. Both microalbuminuria and macroalbuminuria in individuals with DM are associated with increased risk of cardiovascular disease.Prevalence of diabetic nephropathy in INDIA- 30.3%.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Thursday 30 July 2026, 05:00:05 (IST)


3369

Accesses

6
295
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share